Considering the extremely low extracellular AMP levels observed in vitro cancer cell culture processes, attributed to the lack of CD39, we introduced the AMP as an approach to mimic the metabolic environment following AB680 treatment in vivo (Figure 6L). Here, ENTPD1 is linked to cancer.